Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes

Cholesteatoma is characterized by both the overgrowth of hyperkeratinized squamous epithelium and bone erosion. However, the exact mechanism underlying the hyperproliferative ability of cholesteatoma remains unknown. In this study, we investigated PPAR β/δ expression in human surgical specimens of c...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen Zhang, Yang-Wenyi Liu, Zhangcai Chi, Bing Chen
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2020/8864813
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563131969175552
author Chen Zhang
Yang-Wenyi Liu
Zhangcai Chi
Bing Chen
author_facet Chen Zhang
Yang-Wenyi Liu
Zhangcai Chi
Bing Chen
author_sort Chen Zhang
collection DOAJ
description Cholesteatoma is characterized by both the overgrowth of hyperkeratinized squamous epithelium and bone erosion. However, the exact mechanism underlying the hyperproliferative ability of cholesteatoma remains unknown. In this study, we investigated PPAR β/δ expression in human surgical specimens of cholesteatoma and analyzed its functional role as a regulator of epithelial keratinocyte hyperproliferation. We found that the expression of PPAR β/δ was significantly upregulated in cholesteatoma and ligand-activated PPAR β/δ markedly promoted the proliferation of cholesteatoma keratinocytes. Furthermore, we showed that PPAR β/δ activation increased PDK1 expression and decreased PTEN generation, which led to increased phosphorylation of AKT and GSK3β and increased the expression level of Cyclin D1. Overall, our data suggested that the proliferating effect of PPAR β/δ on the cholesteatoma keratinocytes was mediated by the positive regulation of the PDK1/PTEN/AKT/GSK3β/Cyclin D1 pathway. These findings warranted further investigation of PPAR β/δ as a therapeutic target for recurrent or residual cholesteatoma.
format Article
id doaj-art-1cb4a9432cbb4e1981cc72512a33b737
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-1cb4a9432cbb4e1981cc72512a33b7372025-02-03T01:20:51ZengWileyPPAR Research1687-47571687-47652020-01-01202010.1155/2020/88648138864813Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma KeratinocytesChen Zhang0Yang-Wenyi Liu1Zhangcai Chi2Bing Chen3ENT Institute and Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, ChinaENT Institute and Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, ChinaENT Institute and Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, ChinaENT Institute and Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, ChinaCholesteatoma is characterized by both the overgrowth of hyperkeratinized squamous epithelium and bone erosion. However, the exact mechanism underlying the hyperproliferative ability of cholesteatoma remains unknown. In this study, we investigated PPAR β/δ expression in human surgical specimens of cholesteatoma and analyzed its functional role as a regulator of epithelial keratinocyte hyperproliferation. We found that the expression of PPAR β/δ was significantly upregulated in cholesteatoma and ligand-activated PPAR β/δ markedly promoted the proliferation of cholesteatoma keratinocytes. Furthermore, we showed that PPAR β/δ activation increased PDK1 expression and decreased PTEN generation, which led to increased phosphorylation of AKT and GSK3β and increased the expression level of Cyclin D1. Overall, our data suggested that the proliferating effect of PPAR β/δ on the cholesteatoma keratinocytes was mediated by the positive regulation of the PDK1/PTEN/AKT/GSK3β/Cyclin D1 pathway. These findings warranted further investigation of PPAR β/δ as a therapeutic target for recurrent or residual cholesteatoma.http://dx.doi.org/10.1155/2020/8864813
spellingShingle Chen Zhang
Yang-Wenyi Liu
Zhangcai Chi
Bing Chen
Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
PPAR Research
title Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
title_full Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
title_fullStr Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
title_full_unstemmed Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
title_short Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
title_sort ligand activated peroxisome proliferator activated receptor β δ facilitates cell proliferation in human cholesteatoma keratinocytes
url http://dx.doi.org/10.1155/2020/8864813
work_keys_str_mv AT chenzhang ligandactivatedperoxisomeproliferatoractivatedreceptorbdfacilitatescellproliferationinhumancholesteatomakeratinocytes
AT yangwenyiliu ligandactivatedperoxisomeproliferatoractivatedreceptorbdfacilitatescellproliferationinhumancholesteatomakeratinocytes
AT zhangcaichi ligandactivatedperoxisomeproliferatoractivatedreceptorbdfacilitatescellproliferationinhumancholesteatomakeratinocytes
AT bingchen ligandactivatedperoxisomeproliferatoractivatedreceptorbdfacilitatescellproliferationinhumancholesteatomakeratinocytes